9588554

Source:http://linkedlifedata.com/resource/pubmed/id/9588554

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0005854, umls-concept:C0302350, umls-concept:C0311417, umls-concept:C1285529, umls-concept:C1704970, umls-concept:C1882151
pubmed:issue	5
pubmed:dateCreated	1998-7-14
pubmed:abstractText	This article reviews historical aspects of the blood-brain barrier (BBB) and recent advances in mechanisms to deliver therapeutic agents across the BBB for the treatment of intracerebral tumors and other neurological diseases.
pubmed:grant	http://linkedlifedata.com/resource/pubmed/grant/CA31770, http://linkedlifedata.com/resource/pubmed/grant/NS33618, http://linkedlifedata.com/resource/pubmed/grant/NS34608
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/7802914
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Bradykinin, http://linkedlifedata.com/resource/pubmed/chemical/Hypertonic Solutions, http://linkedlifedata.com/resource/pubmed/chemical/Immunotoxins, http://linkedlifedata.com/resource/pubmed/chemical/Mannitol
pubmed:status	MEDLINE
pubmed:month	May
pubmed:issn	0148-396X
pubmed:author	pubmed-author:KrollR ARA, pubmed-author:NeuweltE AEA
pubmed:issnType	Print
pubmed:volume	42
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1083-99; discussion 1099-100
pubmed:dateRevised	2007-11-15
pubmed:meshHeading	pubmed-meshheading:9588554-Animals, pubmed-meshheading:9588554-Antineoplastic Agents, pubmed-meshheading:9588554-Blood-Brain Barrier, pubmed-meshheading:9588554-Bradykinin, pubmed-meshheading:9588554-Brain Neoplasms, pubmed-meshheading:9588554-Clinical Trials, Phase I as Topic, pubmed-meshheading:9588554-Cognition Disorders, pubmed-meshheading:9588554-Cranial Irradiation, pubmed-meshheading:9588554-Dogs, pubmed-meshheading:9588554-Forecasting, pubmed-meshheading:9588554-Gene Therapy, pubmed-meshheading:9588554-Hearing Loss, pubmed-meshheading:9588554-Humans, pubmed-meshheading:9588554-Hypertonic Solutions, pubmed-meshheading:9588554-Immunotoxins, pubmed-meshheading:9588554-Life Tables, pubmed-meshheading:9588554-Lysosomal Storage Diseases, pubmed-meshheading:9588554-Mannitol, pubmed-meshheading:9588554-Osmotic Pressure, pubmed-meshheading:9588554-Parkinson Disease, pubmed-meshheading:9588554-Pharmacokinetics, pubmed-meshheading:9588554-Quality of Life, pubmed-meshheading:9588554-Rats, pubmed-meshheading:9588554-Rats, Nude, pubmed-meshheading:9588554-Survival Analysis
pubmed:year	1998
pubmed:articleTitle	Outwitting the blood-brain barrier for therapeutic purposes: osmotic opening and other means.
pubmed:affiliation	Department of Neurology, Oregon Health Sciences University, Portland 97201, USA.
pubmed:publicationType	Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, U.S. Gov't, Non-P.H.S., Review, Research Support, Non-U.S. Gov't